Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THS
1051
DELISTED
Treehouse Foods
THS
| $5.63M | 0.01% |
104,151
+2,100
| +2% | +$123K |
|
|
CMD
1052
DELISTED
Cantel Medical Corporation
CMD
| $5.63M | 0.01% |
69,850
+1,400
| +2% | +$98.4K |
|
|
NUVA
1053
DELISTED
NuVasive, Inc.
NUVA
| $5.62M | 0.01% |
96,069
+2,400
| +3% | +$142K |
|
1054
Exponent
EXPO
$3.25B
| $5.61M | 0.01% |
95,900
+1,100
| +1% | +$62.6K |
|
1055
Hilton Grand Vacations
HGV
$3.34B
| $5.6M | 0.01% |
176,060
-600
| -0.3% | -$17.8K |
|
|
MNDT
1056
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.6M | 0.01% |
377,900
+36,800
| +11% | +$564K |
|
1057
Navient
NAVI
$803M
| $5.59M | 0.01% |
409,500
-35,000
| -8% | -$456K |
|
1058
Graham Holdings Company
GHC
$4.97B
| $5.59M | 0.01% |
8,100
+200
| +3% | +$140K |
|
1059
Terreno Realty
TRNO
$7.44B
| $5.58M | 0.01% |
113,800
+6,000
| +6% | +$272K |
|
1060
Q2 Holdings
QTWO
$3.95B
| $5.57M | 0.01% |
73,000
+5,800
| +9% | +$419K |
|
|
UNVR
1061
DELISTED
Univar Solutions Inc.
UNVR
| $5.57M | 0.01% |
252,638
+5,500
| +2% | +$120K |
|
|
VEDL
1062
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $5.57M | 0.01% |
547,220
| – | – |
|
1063
Protolabs
PRLB
$2.16B
| $5.53M | 0.01% |
47,700
+800
| +2% | +$86.1K |
|
|
TGE
1064
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
| $5.53M | 0.01% |
261,900
-23,000
| -8% | -$544K |
|
|
GBT
1065
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.51M | 0.01% |
104,800
+14,400
| +16% | +$828K |
|
1066
EnerSys
ENS
$6.79B
| $5.49M | 0.01% |
80,100
+3,300
| +4% | +$216K |
|
|
TCF
1067
DELISTED
TCF Financial Corporation Common Stock
TCF
| $5.46M | 0.01% |
132,903
+2,700
| +2% | +$112K |
|
1068
Avista
AVA
$3.22B
| $5.46M | 0.01% |
122,300
+2,600
| +2% | +$111K |
|
1069
Unifirst Corp
UNF
$5.27B
| $5.43M | 0.01% |
28,800
+2,100
| +8% | +$340K |
|
1070
Qualys
QLYS
$6.51B
| $5.42M | 0.01% |
62,300
+1,300
| +2% | +$112K |
|
1071
Carvana
CVNA
$79.2B
| $5.41M | 0.01% |
+432,500
| New | +$5.55M |
|
|
CSOD
1072
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $5.41M | 0.01% |
93,400
+8,000
| +9% | +$433K |
|
1073
COPT Defense Properties
CDP
$4.13B
| $5.41M | 0.01% |
205,100
+6,700
| +3% | +$187K |
|
|
ARNA
1074
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.39M | 0.01% |
91,930
+1,900
| +2% | +$98.2K |
|
|
CADE
1075
DELISTED
Cadence Bank
CADE
| $5.37M | 0.01% |
185,000
+12,500
| +7% | +$363K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.